rxstat › Classes › Psychostimulants And Nootropics

Psychostimulants And Nootropics: shortage status in Canada

6 of the 6 psychostimulants and nootropics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Partial shortageAtomoxetine13 of 63 reported products affected · est. return Dec 31, 2026Partial shortageDextroamphetamine2 of 6 reported products affected · est. return Jul 20, 2026Partial shortageLisdexamfetamine3 of 18 reported products affected · est. return Jul 24, 2026Partial shortageMethylphenidate7 of 59 reported products affected · est. return Oct 3, 2026Partial shortageMixed Salts Amphetamine3 of 25 reported products affected · est. return Jun 19, 2026Partial shortageModafinil1 of 6 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.